Stock 8067 GISH INTERNATIONAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Gish International Co., Ltd

Equities

8067

TW0008067000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
16.6 TWD +1.84% Intraday chart for Gish International Co., Ltd 0.00% +21.17%
15/05 Gish International Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/03 Gish International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 188.1 245 269.7 295.8 264.9 283.6
Enterprise Value (EV) 1 361.6 496.9 506.2 394.5 381.8 360.4
P/E ratio -2.74 x -5.76 x -7.96 x -10.7 x -13.8 x -17.7 x
Yield - - - - - -
Capitalization / Revenue 1.22 x 1.03 x 1.04 x 1.3 x 1.81 x 2.73 x
EV / Revenue 2.35 x 2.1 x 1.95 x 1.73 x 2.61 x 3.46 x
EV / EBITDA -5.78 x -12.6 x -17.3 x -15.4 x -17.3 x -11.5 x
EV / FCF -1.99 x -6.86 x -42.1 x 2.64 x 298 x 93.7 x
FCF Yield -50.4% -14.6% -2.38% 37.9% 0.34% 1.07%
Price to Book 0.9 x 1.28 x 1.33 x 1.7 x 1.78 x 1.67 x
Nbr of stocks (in thousands) 12,110 14,417 17,300 17,300 17,300 20,700
Reference price 2 15.53 16.99 15.59 17.10 15.31 13.70
Announcement Date 29/03/19 31/03/20 31/03/21 30/03/22 29/03/23 21/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 154 236.9 259 228.4 146.5 104
EBITDA 1 -62.6 -39.59 -29.29 -25.67 -22.04 -31.45
EBIT 1 -65.87 -42.69 -31.77 -27.56 -23.28 -32.73
Operating Margin -42.78% -18.03% -12.27% -12.07% -15.89% -31.46%
Earnings before Tax (EBT) 1 -62.21 -43.3 -29.96 -26.43 -20.32 -15.25
Net income 1 -68.7 -47.53 -31.55 -27.62 -19.13 -15
Net margin -44.62% -20.07% -12.18% -12.09% -13.06% -14.42%
EPS 2 -5.673 -2.953 -1.959 -1.597 -1.106 -0.7721
Free Cash Flow 1 -182.2 -72.38 -12.03 149.5 1.281 3.846
FCF margin -118.3% -30.56% -4.65% 65.47% 0.87% 3.7%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 29/03/19 31/03/20 31/03/21 30/03/22 29/03/23 21/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 174 252 237 98.7 117 76.8
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -2.772 x -6.362 x -8.074 x -3.843 x -5.306 x -2.443 x
Free Cash Flow 1 -182 -72.4 -12 150 1.28 3.85
ROE (net income / shareholders' equity) -28.1% -23.4% -15.9% -14.5% -11.7% -9.81%
ROA (Net income/ Total Assets) -8.1% -5.28% -3.94% -4% -4.02% -5.66%
Assets 1 847.7 899.6 801.5 691.1 476.1 264.9
Book Value Per Share 2 17.20 13.30 11.70 10.10 8.610 8.210
Cash Flow per Share 2 1.320 0.6600 0.8500 1.530 0.6700 0.4700
Capex 1 0.04 33.6 0.19 - 0.05 -
Capex / Sales 0.03% 14.2% 0.07% - 0.03% -
Announcement Date 29/03/19 31/03/20 31/03/21 30/03/22 29/03/23 21/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
GISH INTERNATIONAL CO., LTD Stock Gish International Co., Ltd
+21.17% 10.55M
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-1.17% 24.26B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+15.06% 8.74B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+1.47% 8.21B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-31.14% 6.87B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+19.41% 5.29B
GALENICA AG Stock Galenica AG
+1.44% 4.13B
EBOS GROUP LIMITED Stock EBOS Group Limited
-9.24% 3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-8.91% 3.34B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+7.11% 3.2B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 8067 Stock
  4. Financials Gish International Co., Ltd